** Shares of XtalPi Holdings 2228.HK rise 6.2% to HK$6.2, their highest level since March 31
** Drug discovery and intelligent automation solutions provider completes acquisition of UK's Liverpool ChiroChem (LCC) Technologies
** Liverpool ChiroChem designs and synthesises tech research and development of novel molecules, especially new chiral molecules
** XtalPi says acquisition will increase its technical strength in chemical space exploration and improves its ability to serve domestic and international customers
** Hong Kong's healthcare index .HSCIH rises 3.6%, Hang Seng Biotech Index .HSHKBIO surges 3.9%
** YTD, stock up 1%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.